The programme will produce students with increased systematic understanding and critical awareness of key emerging therapeutic technologies, increasing the provision in identified skills needs.
The overall teaching and learning strategy for the programme is designed to be flexible, accessible and responsive so that students can access quality, evidence-based learning and professional development.
The programme will be delivered in a blended learning environment and underpinned by a small group, problem-based and peer learning ethos. It will also incorporate active learning techniques with a mix of team-based and individual-focused projects and a significant practical focus with a view to ensuring workplace readiness.
The MSc in Technologies and Analytics in Precision Medicine at RCSI is offered as a full-time, 12-month programme, or as a two-year programme from September 2022. Both programmes carry 90 ECTS credits in total: 15 credits for each taught block and 30 credits for research methods and research project. The course offers exit routes at MSc (90 ECTS credits), Diploma (60 ECTS credits) and Certificate (30 ECTS credits).
For any queries, please email email@example.com.
Two-year full-time programme with industry placement
The School of Pharmacy and Biomolecular Sciences also offer a two-year programme with a nine-month industry placement for Year 2 – Masters in Technologies and Analytics in Precision Medicine with Industry.
Interested students undertaking the Masters in Technologies, Analytics and Precision Medicine can apply in Year 1, Semester 2 to transfer to this extended two-year programme*.
This unique opportunity enables students to apply the practical skills and theory learnt on the programme to real-life projects with our industry partners. Our two-year programme further supports students who are looking to establish industry network connections and create further career prospects.
*Placements are limited and are subject to availability under an application process. Additional tuition fees will apply.